» Articles » PMID: 34764440

Quantitative Imaging of Apoptosis Following Oncolytic Virotherapy by Magnetic Resonance Fingerprinting Aided by Deep Learning

Overview
Journal Nat Biomed Eng
Publisher Springer Nature
Date 2021 Nov 12
PMID 34764440
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Non-invasive imaging methods for detecting intratumoural viral spread and host responses to oncolytic virotherapy are either slow, lack specificity or require the use of radioactive or metal-based contrast agents. Here we show that in mice with glioblastoma multiforme, the early apoptotic responses to oncolytic virotherapy (characterized by decreased cytosolic pH and reduced protein synthesis) can be rapidly detected via chemical-exchange-saturation-transfer magnetic resonance fingerprinting (CEST-MRF) aided by deep learning. By leveraging a deep neural network trained with simulated magnetic resonance fingerprints, CEST-MRF can generate quantitative maps of intratumoural pH and of protein and lipid concentrations by selectively labelling the exchangeable amide protons of endogenous proteins and the exchangeable macromolecule protons of lipids, without requiring exogenous contrast agents. We also show that in a healthy volunteer, CEST-MRF yielded molecular parameters that are in good agreement with values from the literature. Deep-learning-aided CEST-MRF may also be amenable to the characterization of host responses to other cancer therapies and to the detection of cardiac and neurological pathologies.

Citing Articles

Improving quantification accuracy of a nuclear Overhauser enhancement signal at -1.6 ppm at 4.7 T using a machine learning approach.

Yin L, Viswanathan M, Kurmi Y, Zu Z Phys Med Biol. 2025; 70(2.

PMID: 39774035 PMC: 11740009. DOI: 10.1088/1361-6560/ada716.


Ungated, plug-and-play preclinical cardiac CEST-MRI using radial FLASH with segmented saturation.

Weigand-Whittier J, Wendland M, Lam B, Velasquez M, Vandsburger M Magn Reson Med. 2024; 93(4):1793-1806.

PMID: 39607872 PMC: 11785487. DOI: 10.1002/mrm.30382.


mapping of the chemical exchange relayed nuclear Overhauser effect using deep magnetic resonance fingerprinting.

Power I, Rivlin M, Shmuely H, Zaiss M, Navon G, Perlman O iScience. 2024; 27(11):111209.

PMID: 39569380 PMC: 11576397. DOI: 10.1016/j.isci.2024.111209.


Enhancing amide proton transfer imaging in ischemic stroke using a machine learning approach with partially synthetic data.

Viswanathan M, Yin L, Kurmi Y, Afzal A, Zu Z NMR Biomed. 2024; 38(1):e5277.

PMID: 39434444 PMC: 11602689. DOI: 10.1002/nbm.5277.


DCE-Qnet: deep network quantification of dynamic contrast enhanced (DCE) MRI.

Cohen O, Kargar S, Woo S, Vargas A, Otazo R MAGMA. 2024; 37(6):1077-1090.

PMID: 39112813 DOI: 10.1007/s10334-024-01189-0.


References
1.
Lichty B, Breitbach C, Stojdl D, Bell J . Going viral with cancer immunotherapy. Nat Rev Cancer. 2014; 14(8):559-67. DOI: 10.1038/nrc3770. View

2.
Markert J, Liechty P, Wang W, Gaston S, Braz E, Karrasch M . Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM. Mol Ther. 2008; 17(1):199-207. PMC: 2834981. DOI: 10.1038/mt.2008.228. View

3.
Tamura K, Wakimoto H, Agarwal A, Rabkin S, Bhere D, Martuza R . Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors. Mol Ther. 2012; 21(1):68-77. PMC: 3538303. DOI: 10.1038/mt.2012.175. View

4.
Cheema T, Wakimoto H, Fecci P, Ning J, Kuroda T, Jeyaretna D . Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model. Proc Natl Acad Sci U S A. 2013; 110(29):12006-11. PMC: 3718117. DOI: 10.1073/pnas.1307935110. View

5.
Kuruppu D, Brownell A, Zhu A, Yu M, Wang X, Kulu Y . Positron emission tomography of herpes simplex virus 1 oncolysis. Cancer Res. 2007; 67(7):3295-300. DOI: 10.1158/0008-5472.CAN-06-4062. View